IL6 and metabolic dysfunction-associated steatohepatitis: The release of ferroptosis-induced IL-6 promotes the recruitment and activation of neutrophils, enhancing their capacity to release reactive ROS and inflammatory mediators, which exacerbates inflammation and oxidative stress in the liver and creats a vicious cycle that drives the progression of NAFLD to NASH and even cirrhosis [28].